Predictors of Test Positivity, Mortality, and Seropositivity during the Early Coronavirus Disease Epidemic, Orange County, California, USA
Daniel M. Parker

, Tim Bruckner, Verónica M. Vieira, Catalina Medina, Vladimir N. Minin, Philip L. Felgner, Alissa Dratch, Matthew Zahn, Scott M. Bartell, and Bernadette Boden-Albala
Author affiliations: University of California, Irvine, Irvine, California, USA (D.M. Parker, T. Bruckner, V.M. Vieira, C. Medina, V.N. Minin, P.L. Felgner, S.M. Bartell, B. Boden-Albala); Orange County Health Care Agency, Santa Ana, California, USA (A. Dratch, M. Zahn)
Main Article
Figure 5
![Severe acute respiratory syndrome coronavirus 2 seropositivity, Orange County, California, USA, July–August 2020. A) Seropositivity at ZIP code level. B) Results from tests of statistical clustering (based on LISA statistics [24]). LISA, local indicators of spatial autocorrelation.](/eid/images/21-0103-F5.jpg)
Figure 5. Severe acute respiratory syndrome coronavirus 2 seropositivity, Orange County, California, USA, July–August 2020. A) Seropositivity at ZIP code level. B) Results from tests of statistical clustering (based on LISA statistics [24]). LISA, local indicators of spatial autocorrelation.
Main Article
Page created: July 23, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.